Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
STXS Quote, Financials, Valuation and Earnings
Last price:
$2.41
Seasonality move
:
5.7%
Day range:
$2.26 - $2.40
52-week range:
$1.54 - $2.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.49x
P/B ratio:
71.37x
Volume:
329.5K
Avg. volume:
268.6K
1-year change:
13.27%
Market cap:
$205.5M
Revenue:
$26.9M
EPS (TTM):
-$0.31
Earnings Data
Next earnings date for STXS
Aug 12
2025
Most recent earnings per share
-$0.07
Beat by $0.00
(May 12/2025)
Consensus Estimate
-$0.07
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STXS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $8.4M | -- | -- | -$0.06 | -- |
| 08/12/2025 | Q2 | $7.8M | -- | -- | -$0.07 | -- |
| 05/12/2025 | Q1 | $6.9M | $7.5M | -$0.07 | -$0.07 | $0.00 |
| 03/03/2025 | Q4 | $6.4M | $6.3M | -$0.09 | -$0.07 | -$0.03 |
| 11/11/2024 | Q3 | $7.1M | $9.2M | -$0.08 | -$0.05 | -$0.03 |
| 08/12/2024 | Q2 | $5.6M | $4.5M | -$0.07 | -$0.05 | -$0.02 |
| 05/13/2024 | Q1 | $7.1M | $6.9M | -$0.06 | -$0.06 | $0.00 |
| 03/04/2024 | Q4 | $7.7M | $4.6M | -$0.06 | -$0.07 | $0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.07 | -$0.06 | -$0.01 |
| 08/10/2023 | Q2 | -- | -- | -$0.07 | -$0.07 | $0.00 |
| 05/09/2023 | Q1 | -- | -- | -$0.07 | -$0.06 | -$0.01 |
| 03/03/2023 | Q4 | -- | -- | -$0.06 | -$0.07 | $0.01 |
| 11/10/2022 | Q3 | -- | -- | -$0.07 | -$0.06 | -$0.01 |
| 08/09/2022 | Q2 | -- | -- | -$0.07 | -$0.06 | -$0.01 |
| 05/10/2022 | Q1 | -- | -- | -$0.06 | -$0.06 | -- |
| 03/03/2022 | Q4 | -- | -- | -$0.05 | -$0.04 | -$0.01 |
| 11/11/2021 | Q3 | -- | -- | -$0.07 | -$0.04 | -$0.03 |
| 08/10/2021 | Q2 | -- | -- | -$0.02 | -$0.03 | $0.01 |
| 05/10/2021 | Q1 | -- | -- | -$0.02 | -$0.03 | $0.01 |
| 02/25/2021 | Q4 | -- | -- | -$0.02 | -$0.03 | $0.01 |
| 11/09/2020 | Q3 | -- | -- | -$0.03 | -$0.03 | $0.00 |
| 08/06/2020 | Q2 | -- | -- | -$0.03 | -$0.05 | $0.02 |
| 05/05/2020 | Q1 | -- | -- | -$0.03 | -$0.03 | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.00 | -- | -- |
| 02/06/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.56 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/22/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/03/2015 | Q3 | -- | -- | -- | -- | -- |
Stereotaxis Earnings Questions
-
How Much did Stereotaxis Generate in Revenue Last Quarter?
Stereotaxis reported $7.5M worth of top line sales in its most recent quarter.
-
Did Stereotaxis Beat Earnings Last Quarter?
Stereotaxis announced earnings per share of -$0.07 which represents a beat of analyst forecast a -$0.07 per share.
-
Is Stereotaxis Profitable?
Stereotaxis reported $4.1M that represents $0.05 per share over the last quarter.
-
What is the Analyst Consensus for Stereotaxis EPS Next Year?
Stereotaxis's earnings are forecast to decrease from -$0.30 per share to -$0.27 per share next year representing a decrease of -13.33%.
-
When is Stereotaxis's Earnings Date?
Stereotaxis's next earnings date is August 12, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
